Talking about PGL, it might be worth talking to them again, as...

Talking about PGL, it might be worth talking to them again, as they have gone nowhere since the PGL/AVX debacle.

Talking about regional licensing agreements, can someone tell me why this wasn't looked at several months ago ?

Drona can't be that stupid that he neglected the risk that none of the big pharma wouldn't be interested, and have a number of fall back options. Can he ?

Now that everything has been closed and staff being made redundant, it is going to be much harder to get a deal done.

Doesn't smell right at all.